1GAG
CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR
1GAG の概要
| エントリーDOI | 10.2210/pdb1gag/pdb |
| 関連するPDBエントリー | 1IR3 |
| 分子名称 | INSULIN RECEPTOR, TYROSINE KINASE DOMAIN, BISUBSTRATE PEPTIDE INHIBITOR, MAGNESIUM ION, ... (5 entities in total) |
| 機能のキーワード | protein kinase inhibitor, tyrosine kinase, transferase, signaling protein, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Membrane; Single-pass type I membrane protein: P06213 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 36985.14 |
| 構造登録者 | Parang, K.,Till, J.H.,Ablooglu, A.J.,Kohanski, R.A.,Hubbard, S.R.,Cole, P.A. (登録日: 2000-11-29, 公開日: 2001-01-17, 最終更新日: 2024-10-30) |
| 主引用文献 | Parang, K.,Till, J.H.,Ablooglu, A.J.,Kohanski, R.A.,Hubbard, S.R.,Cole, P.A. Mechanism-based design of a protein kinase inhibitor. Nat.Struct.Biol., 8:37-41, 2001 Cited by PubMed Abstract: Protein kinase inhibitors have applications as anticancer therapeutic agents and biological tools in cell signaling. Based on a phosphoryl transfer mechanism involving a dissociative transition state, a potent and selective bisubstrate inhibitor for the insulin receptor tyrosine kinase was synthesized by linking ATPgammaS to a peptide substrate analog via a two-carbon spacer. The compound was a high affinity competitive inhibitor against both nucleotide and peptide substrates and showed a slow off-rate. A crystal structure of this inhibitor bound to the tyrosine kinase domain of the insulin receptor confirmed the key design features inspired by a dissociative transition state, and revealed that the linker takes part in the octahedral coordination of an active site Mg2+. These studies suggest a general strategy for the development of selective protein kinase inhibitors. PubMed: 11135668DOI: 10.1038/83028 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.7 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






